Empagliflozin vs Lansoprazole
Empagliflozin vs Lansoprazole: Overview
This comparison examines the pharmacological differences between Empagliflozin and Lansoprazole.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Lansoprazole: Proton pump inhibitor.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Lansoprazole β 1.5 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Lansoprazole β C16H14F3N3O2S.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Lansoprazole β 369.3620 g/mol.
Type: Empagliflozin β Small molecule; Lansoprazole β Small molecule.